Not all head-to-head trials are created equal: results from an open-label, short-term study seem inconsistent with previous donepezil literature.
Bullock
Roger
R
Truyen
Luc
L
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D017028:Caregivers; D003071:Cognition; D000077265:Donepezil; D005702:Galantamine / Q000627:therapeutic use; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016896:Treatment Outcome
D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D005702:Galantamine; D000077265:Donepezil